The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective
Open accessAbstract
Cancer is defined as the abnormal cell growth that can cause life-threatening malignancies with high financial costs for patients as well as the health care system. Natural polyphenols have long been used for the prevention and treatment of several disorders due to their antioxidant, anti-inflammatory, cytotoxic, antineoplastic, and immunomodulatory effects discussed in the literature; thus, these phytochemicals are potentially able to act as chemopreventive and chemotherapeutic agents in different types of cancer. One of the problems regarding the use of polyphenolic compounds is their low bioavailability. Different types of formulations have been designed for the improvement of bioavailability of these compounds, nanonization being one of the most notable approaches among them. This study aimed to review current data on the nanoformulations of natural polyphenols as chemopreventive and chemotherapeutic agents and to discuss their molecular anticancer mechanisms of action. Nanoformulations of natural polyphenols as bioactive agents, including resveratrol, curcumin, quercetin, epigallocatechin-3-gallate, chrysin, baicalein, luteolin, honokiol, silibinin, and coumarin derivatives, in a dose-dependent manner, result in better efficacy for the prevention and treatment of cancer. The impact of nanoformulation methods for these natural agents on tumor cells has gained wider attention due to improvement in targeted therapy and bioavailability, as well as enhancement of stability. Today, several nanoformulations are designed for delivery of polyphenolic compounds, including nanosuspensions, solid lipid nanoparticles, liposomes, gold nanoparticles, and polymeric nanoparticles, which have resulted in better antineoplastic activity, higher intracellular concentration of polyphenols, slow and sustained release of the drugs, and improvement of proapoptotic activity against tumor cells. To conclude, natural polyphenols demonstrate remarkable anticancer potential in pharmacotherapy; however, the obstacles in terms of their bioavailability in and toxicity to normal cells, as well as targeted drug delivery to malignant cells, can be overcome using nanoformulation-based technologies, which optimize the bioefficacy of these natural drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Brocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
microRNAs as oncogenes and tumor suppressors
Zhang, B., Pan, X., Cobb, G. P., & Anderson, T. A. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.028 · Cited by 2,749
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Pinto Reis, C., Neufeld, R. J., Ribeiro, & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,354
Poly-ϵ-caprolactone microspheres and nanospheres: an overview
Sinha, V. R., Bansal, K., Kaushik, R., Kumria, R., & Trehan, A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.044 · Cited by 1,100
Parhiz, H., Roohbakhsh, A., Soltani, F., Rezaee, R., & Iranshahi, M. (2015) · Phytotherapy Research · doi:10.1002/ptr.5256 · Cited by 908
Multitargeted cancer prevention by quercetin
Murakami, A., Ashida, H., & Terao, J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.046 · Cited by 721
Anthocyanins and other flavonoids
Williams, C. A., & Grayer, R. J. (2004) · Natural Product Reports · doi:10.1039/b311404j · Cited by 689
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623
Pyruvate kinase: Function, regulation and role in cancer
Israelsen, W. J., & Vander Heiden, M. G. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.08.004 · Cited by 589
Cancer preventive effects of flavonoids—a review
Le Marchand, L. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(02)00186-5 · Cited by 583
Yallapu, M. M., Gupta, B. K., Jaggi, M., & Chauhan, S. C. (2010) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2010.05.022 · Cited by 579
Adlercreutz, H. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701612942 · Cited by 547
Plasma antioxidants from chocolate
Serafini, M., Bugianesi, R., Maiani, G., Valtuena, S., De Santis, S., & Crozier, A. (2003) · Nature · doi:10.1038/4241013a · Cited by 539
Cytotoxicity of dietary flavonoids on different human cancer types
Sak, K. (2014) · Pharmacognosy Reviews · doi:10.4103/0973-7847.134247 · Cited by 461
Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis
Donnenberg, V. S., & Donnenberg, A. D. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005276905 · Cited by 457
Self-Association of Cyclodextrins and Cyclodextrin Complexes
Loftsson, T., Másson, M., & Brewster, M. E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20047 · Cited by 426
Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in Vitaceae
Rivière, C., Pawlus, A. D., & Mérillon, J.-M. (2012) · Natural Product Reports · doi:10.1039/c2np20049j · Cited by 407
Touré, A., & Xueming, X. (2010) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2009.00105.x · Cited by 406
Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases
Leyva-López, N., Gutierrez-Grijalva, E., Ambriz-Perez, D., & Heredia, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060921 · Cited by 337
Circumventing Tumor Resistance to Chemotherapy by Nanotechnology
Liang, X.-J., Chen, C., Zhao, Y., & Wang, P. C. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_21 · Cited by 330
Casadio, F., Leona, M., Lombardi, J. R., & Van Duyne, R. (2010) · Accounts of Chemical Research · doi:10.1021/ar100019q · Cited by 324
Gupta, S., Afaq, F., & Mukhtar, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205474 · Cited by 295
Medicinal plants used in treatment and management of cancer in Kakamega County, Kenya
Ochwang’i, D. O., Kimwele, C. N., Oduma, J. A., Gathumbi, P. K., Mbaria, J. M., & Kiama, S. G. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.11.051 · Cited by 270
Identification of baicalein as a ferroptosis inhibitor by natural product library screening
Xie, Y., Song, X., Sun, X., Huang, J., Zhong, M., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.052 · Cited by 243
Advances of Cancer Therapy by Nanotechnology
Wang, X., Wang, Y., Chen, Z. G., & Shin, D. M. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.1.1 · Cited by 230
Yallapu, M. M., Maher, D. M., Sundram, V., Bell, M. C., Jaggi, M., & Chauhan, S. C. (2010) · Journal of Ovarian Research · doi:10.1186/1757-2215-3-11 · Cited by 221
Wu, G., Huang, H., Abreu, J. G., & He, X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004926 · Cited by 216
Beck-Broichsitter, M., Rytting, E., Lebhardt, T., Wang, X., & Kissel, T. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.06.007 · Cited by 213
Nuclear delivery of macromolecules: barriers and carriers
BELTING, M., SANDGREN, S., & WITTRUP, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.004 · Cited by 209
Leal, L. K. A. M., Ferreira, A. A. G., Bezerra, G. A., Matos, F. J. A., & Viana, G. S. B. (2000) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(99)00165-8 · Cited by 205
Curcumin Nanoformulation for Cervical Cancer Treatment
Zaman, M. S., Chauhan, N., Yallapu, M. M., Gara, R. K., Maher, D. M., Kumari, S., Sikander, M., Khan, S., Zafar, N., Jaggi, M., et al. (2016) · Scientific Reports · doi:10.1038/srep20051 · Cited by 205
Antioxidants: Friends or foe in prevention or treatment of cancer: The debate of the century
Saeidnia, S., & Abdollahi, M. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.05.004 · Cited by 190
Self-citationAyoub, M., de Camargo, A. C., & Shahidi, F. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2015.10.107 · Cited by 188
Panahi, Y., Badeli, R., Karami, G., & Sahebkar, A. (2015) · Phytotherapy Research · doi:10.1002/ptr.5211 · Cited by 186
Shao, J., Li, X., Lu, X., Jiang, C., Hu, Y., Li, Q., You, Y., & Fu, Z. (2009) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.03.010 · Cited by 172
Flavonoids and Immune Function in Human: A Systematic Review
Peluso, I., Miglio, C., Morabito, G., Ioannone, F., & Serafini, M. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2012.656770 · Cited by 168
Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity
Majumdar, D., Jung, K.-H., Zhang, H., Nannapaneni, S., Wang, X., Amin, A. R. M. R., Chen, Z., Chen, Z. (., & Shin, D. M. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0230 · Cited by 167
Sanna, V., Siddiqui, I. A., Sechi, M., & Mukhtar, H. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400342f · Cited by 166
Sanoj Rejinold, N., Sreerekha, P. R., Chennazhi, K. P., Nair, S. V., & Jayakumar, R. (2011) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2011.04.008 · Cited by 164
Ghosh, D., Choudhury, S. T., Ghosh, S., Mandal, A. K., Sarkar, S., Ghosh, A., Saha, K. D., & Das, N. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.12.004 · Cited by 164
Liposomes: Versatile and Biocompatible Nanovesicles for Efficient Biomolecules Delivery
Mallick, S., & Choi, J. S. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.9080 · Cited by 163
Siddiqui, I. A., Bharali, D. J., Nihal, M., Adhami, V. M., Khan, N., Chamcheu, J. C., Khan, M. I., Shabana, S., Mousa, S. A., & Mukhtar, H. (2014) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.05.007 · Cited by 158
Anthocyanins and other flavonoids
Harborne, J. B., & Williams, C. A. (1995) · Natural Product Reports · doi:10.1039/np9951200639 · Cited by 155
Rezaei-Sadabady, R., Eidi, A., Zarghami, N., & Barzegar, A. (2014) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2014.926456 · Cited by 149
Liposomes as drug carriers: a technological approach
Brandl, M. (2001) · Biotechnology annual review · doi:10.1016/s1387-2656(01)07033-8 · Cited by 147
Mohanty, C., Acharya, S., Mohanty, A. K., Dilnawaz, F., & Sahoo, S. K. (2010) · Nanomedicine · doi:10.2217/nnm.10.9 · Cited by 147
Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles
Aldahoun, M. A., Al-Akhras, M.-A. H., Jaafar, M. S., & Bououdina, M. (2016) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1129628 · Cited by 141
Prabaharan, M., Grailer, J. J., Steeber, D. A., & Gong, S. (2008) · Macromolecular Bioscience · doi:10.1002/mabi.200800010 · Cited by 139
Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells
Minaei, A., Sabzichi, M., Ramezani, F., Hamishehkar, H., & Samadi, N. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-3942-x · Cited by 137
Yang, Y. L., Zhang, X., & Qiu, L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.096 · Cited by 132
Anandhi, R., Thangaraj, A., Anitha, T. S., Muralidharan, A. R., Najmunnisha, K., Nachiappan, V., Thomas, P. A., & Geraldine, P. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0215-6 · Cited by 129
Punfa, W., Yodkeeree, S., Pitchakarn, P., Ampasavate, C., & Limtrakul, P. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.34 · Cited by 128
Sabzichi, M., Hamishehkar, H., Ramezani, F., Sharifi, S., Tabasinezhad, M., Pirouzpanah, M., Ghanbari, P., & Samadi, N. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.13.5311 · Cited by 127
Real time in vitro studies of doxorubicin release from PHEMA nanoparticles
Chouhan, R., & Bajpai, A. (2009) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-7-5 · Cited by 116
Mohan, A., Narayanan, S., Sethuraman, S., & Krishnan, U. M. (2014) · BioMed Research International · doi:10.1155/2014/424239 · Cited by 115
Targeted therapy against Bcl-2-related proteins in breast cancer cells
Emi, M., Kim, R., Tanabe, K., Uchida, Y., & Toge, T. (2005) · Breast Cancer Research · doi:10.1186/bcr1323 · Cited by 114
Narayanan, S., Mony, U., Vijaykumar, D. K., Koyakutty, M., Paul‐Prasanth, B., & Menon, D. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.03.015 · Cited by 112
Kumar, S. S. D., Mahadevan, S., Vijayaraghavan, R. K., Mandal, A. B., & MacFarlane, D. R. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.036 · Cited by 112
Xie, M., Fan, D., Zhao, Z., Li, Z., Li, G., Chen, Y., He, X., Chen, A., Li, J., Lin, X., et al. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.11.016 · Cited by 110
Resveratrol-loaded nanocapsules inhibit murine melanoma tumor growth
Carletto, B., Berton, J., Ferreira, T. N., Dalmolin, L. F., Paludo, K. S., Mainardes, R. M., Farago, P. V., & Fávero, G. M. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.001 · Cited by 104
Shiri, S., Alizadeh, A. M., Baradaran, B., Farhanghi, B., Shanehbandi, D., Khodayari, S., Khodayari, H., & Tavasoli, A. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.3917 · Cited by 96
Ochi, M. M., Amoabediny, G., Rezayat, S. M., Akbarzadeh, A., & Ebrahimi, B. (2016) · Europe PMC (PubMed Central) · doi:10.22074/cellj.2016.4308 · Cited by 92
Paleos, C. M., Tsiourvas, D., Sideratou, Z., & Pantos, A. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.011 · Cited by 83
Fang, X., Zhang, J., Xie, X., Liu, D., He, C., Wan, J., & Chen, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.029 · Cited by 83
Liu, A., Wang, W., Fang, H., et al. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.12.014 · Cited by 82
Abdolahad, M., Janmaleki, M., Mohajerzadeh, S., Akhavan, O., & Abbasi, S. (2012) · Materials Science and Engineering C · doi:10.1016/j.msec.2012.12.052 · Cited by 82
Rasouli, H., Farzaei, M. H., Mansouri, K., Mohammadzadeh, S., & Khodarahmi, R. (2016) · Molecules · doi:10.3390/molecules21091104 · Cited by 82
Self-citationBhattacharyya, S. S., Paul, S., De, A. K., Das, D., Samadder, A., Boujedaini, N., & Khuda‐Bukhsh, A. R. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.04.010 · Cited by 81
Raveendran, R., Bhuvaneshwar, G. S., & Sharma, C. P. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.11.017 · Cited by 81
Different biokinetics of nanomedicines linking to their toxicity; an overview
Mostafalou, S., Mohammadi, H., Ramazani, A., & Abdollahi, M. R. (2013) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-21-14 · Cited by 78
Self-citationHemraz, U. D., Campbell, K. A., Burdick, J. S., Ckless, K., Boluk, Y., & Sunasee, R. (2014) · Biomacromolecules · doi:10.1021/bm501516r · Cited by 77
Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53
Li, X., Huang, J., Wang, J., Xiong, X.-K., Yang, X., & Zou, F. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.03.003 · Cited by 76
Current Opinion on Nanotoxicology
Pourmand, A., & Abdollahi, M. R. (2012) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-20-95 · Cited by 74
Self-citationMeng, G., Chai, K., Li, X., Zhu, Y., & Huang, W. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.07.028 · Cited by 72
Polymer‐Coated Magnetic Nanoparticles for Curcumin Delivery to Cancer Cells
Mancarella, S., Greco, V., Baldassarre, F., Vergara, D., Maffia, M., & Leporatti, S. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500142 · Cited by 70
Phan, Q. T., Le, M. H., Le, T. T. H., Tran, T. H. H., Xuan, P. N., & Ha, P. T. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.05.003 · Cited by 68
Xu, T., Shen, H., Liu, L., & Shu, Y. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2325 · Cited by 67
Milano, F., Mari, L., van de Luijtgaarden, W., Parikh, K., Calpe, S., & Krishnadath, K. K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00137 · Cited by 66
Role of Natural Phenolic Compounds in Cancer Chemoprevention via Regulation of the Cell Cycle
Jafari, S., Saeidnia, S., & Abdollahi, M. R. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140813124832 · Cited by 59
Self-citationKalman, D., Feldman, S., Feldman, R., Schwartz, H. I., Krieger, D., & Garrison, R. (2008) · Nutrition Journal · doi:10.1186/1475-2891-7-11 · Cited by 58
Shin, Y. S., Kang, S. U., Park, J. K., Kim, Y. E., Kim, Y. S., Baek, S. J., Lee, S., & Kim, C. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.07.005 · Cited by 53
Duraipandy, N., Lakra, R., Srivatsan, K. V., Samanta, D., Purna Sai, K., & Kiran, M. S. (2014) · Metallomics · doi:10.1039/c4mt00165f · Cited by 43
Ji, G., Yang, J., & Chen, J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.03.030 · Cited by 41
Risk factors for bleeding in patients taking coumarins.
Beyth, R. J., Milligan, P. E., & Gage, B. F. (2002) · PubMed · Cited by 40
Shafiei, S. S., Solati‐Hashjin, M., Samadikuchaksaraei, A., Kalantarinejad, R., Asadi‐Eydivand, M., & Osman, N. A. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136530 · Cited by 39
Opportunities and obstacles to the development of nanopharmaceuticals for human use
Koopaei, N. N., & Abdollahi, M. R. (2016) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/s40199-016-0163-8 · Cited by 34
Self-citationDendrosomal nano-curcumin; The novel formulation to improve the anticancer properties of curcumin
Birgani, M. T., Moghadam, V. E., Babaei, E., Najafi, F., Zamani, M., Shariati, M., Nazem, S., Farhangi, B., Motahari, P., & Sadeghizadeh, M. (2015) · doi:10.22059/pbs.2015.55525 · Cited by 33
Guo, L., Peng, Y., Li, Y., Yao, J., Zhang, G., Chen, J., Wang, J., & SUI, L. (2015) · Oncology Letters · doi:10.3892/ol.2015.2851 · Cited by 32
Qiu, N., Cai, L., Xie, D., Wang, G., Wu, W., Zhang, Y., Song, H., Yin, H., & Chen, L. (2010) · Biomedical Materials · doi:10.1088/1748-6041/5/6/065006 · Cited by 19
Lucena, G. M. R. S., MATHEUS, F. C., Ferreira, V. M. M., Tessele, P. B., Azevedo, M. S. D., Filho, V. C., & Prediger, R. D. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12022 · Cited by 6
Cited by
Soleimani, V., Sahebkar, A., & Hosseinzadeh, H. (2018) · Phytotherapy Research · doi:10.1002/ptr.6054 · Cited by 579
Therapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer
Avgoulas, D. I., Tasioulis, K. S., Papi, R. M., & Pantazaki, A. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051439 · Cited by 57
Metadata
- Authors
- Davatgaran-Taghipour, Y., Masoomzadeh, S., Farzaei, M. H., Bahramsoltani, R., Karimi-Soureh, Z., Rahimi, R., & Abdollahi, M.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2017-04
- Volume
- Volume 12
- Pages
- 2689-2702
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2604124458
- Cited by
- 281
- References
- 96
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.